ELVN - Enliven Therapeutics Inc
IEX Last Trade
21.88
-0.340 -1.554%
Share volume: 137,597
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$22.22
-0.34
-1.53%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Cash flow financing | |
| Other financing cash flows | |
| Cash flow | |
| Net income | |
| Depreciation | |
| Changes in inventories | |
| Changes in receivables | |
| Investing Cashflow | |
| Net Borrowings | |
| Investing Activity Other | |
| Dividends Paid | |
| Exchange Rate Effect | |
| Capital Expenditures | |
| Cash Change |